I Thought it was interesting to see this article below from Moorfield
Moorfield is proud to celebrate Macular Week (24-30 June). Led by the Macular Society, Macular Week aims to raise awareness of macular disease, the biggest cause of sight loss in the UK. Around 300 people every day in the UK are diagnosed with macular disease, which causes the loss of central vision.
To mark the occasion, we have been reflecting on a ground-breaking clinical study we completed last year, where wet age related macular degeneration (AMD) patients were able to regain their sight after receiving retinal tissue engineered from stem cells. This was the first time a completely engineered tissue has been successfully used in this way and it is hoped that this treatment could be extended to also treat dry AMD in future.
This study was a key milestone in the London Project to Cure Blindness, a partnership between University College London and Moorfields Eye Hospital, which aims to bring stem cell therapy for retinal diseases, especially AMD, to the clinic as rapidly as possible.
Mervyn Walker, Chair of Trustees for Moorfields Eye Charity, who part funded this project with the support of generous donors, said: “Douglas Waters was the first patient to receive treatment for AMD as part of the London Project to Cure Blindness. I met Douglas and his wife recently at the unveiling of UCL’s major donor wall, and they told me that Douglas has fully regained his sight thanks to the treatment he received at Moorfields and described the huge impact that’s had on both of their lives.”
The Friends of Moorfields are celebrating Macular Week by joining forces with the Macular Society to host a series of information stands at our City Road site. These stands aim to raise awareness of macular disease and provide information and support to patients and healthcare professionals. These will take place on Tuesday 25 June, 10am-4pm and Wednesday 26 June, 10am-6pm.
To keep up to date with Moorfields’ activities supporting Macular Week, follow us on Facebook and Twitter.
It’s good to see new treatments are on the horizon!
Best regards to all
Ann